Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives

Carla Rognoni, Arianna Bertolani, CLAUDIO JOMMI

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
Rivista	GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT
Volume	XX
DOI	https://doi.org/10.1177/2284240318784289
Stato di pubblicazione	Pubblicato - 2018

Accesso al documento

@article{b27baf1875aa4f9ea75b08bbe07cd993,

title = "Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives",

author = "Carla Rognoni and Arianna Bertolani and CLAUDIO JOMMI",

year = "2018",

doi = "10.1177/2284240318784289",

language = "English",

volume = "XX",

journal = "GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT",

issn = "2284-2403",

publisher = "AboutScience Srl",

}

TY - JOUR

T1 - Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives

AU - Rognoni, Carla

AU - Bertolani, Arianna

AU - JOMMI, CLAUDIO

PY - 2018

Y1 - 2018

UR - https://iris.uniupo.it/handle/11579/163814

U2 - 10.1177/2284240318784289

DO - 10.1177/2284240318784289

M3 - Article

SN - 2284-2403

VL - XX

JO - GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT

JF - GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT

ER -